PCM
Prelude Capital Management Portfolio holdings
AUM
$1.02B
1-Year Return
30.93%
This Quarter Return
+16.81%
1 Year Return
+30.93%
3 Year Return
+112.01%
5 Year Return
+170.21%
10 Year Return
+650.33%
AUM
$1.02B
AUM Growth
+$33.1M
(+3.3%)
Cap. Flow
-$68M
Cap. Flow
% of AUM
-6.63%
Top 10 Holdings %
Top 10 Hldgs %
14.09%
Holding
1,409
New
335
Increased
269
Reduced
340
Closed
419
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$14.7M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$11.7M |
| 3 |
NVIDIA
NVDA
|
+$11M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$10.6M |
| 5 |
Tesla
TSLA
|
+$10.5M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$11.8M |
| 2 |
Core Scientific
CORZ
|
+$10.8M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$10.4M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$9.34M |
| 5 |
Oracle
ORCL
|
+$9.13M |
Sector Composition
| 1 | Technology | 18.95% |
| 2 | Consumer Discretionary | 12.77% |
| 3 | Healthcare | 12.04% |
| 4 | Communication Services | 10.38% |
| 5 | Industrials | 9.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KGEI
926
Kolibri Global Energy
KGEI
$191M
| $83.4K | 0.01% |
+12,175
| New | +$83.4K |
|
927
Protalix BioTherapeutics
PLX
$135M
| $83K | 0.01% |
+56,055
| New | +$83K |
|
928
Arvinas
ARVN
$575M
| $81.3K | 0.01% |
11,045
-52,695
| -83% | -$388K |
|
929
Arbutus Biopharma
ABUS
$886M
| $78.2K | 0.01% |
+25,318
| New | +$78.2K |
|
930
4D Molecular Therapeutics
FDMT
$324M
| $76.8K | 0.01% |
20,700
-1,800
| -8% | -$6.68K |
|
931
Clarus
CLAR
$149M
| $73.6K | 0.01% |
21,200
+2,800
| +15% | +$9.72K |
|
|
ATYR
932
aTyr Pharma
ATYR
$513M
| $73.4K | 0.01% |
14,481
-6,837
| -32% | -$34.7K |
|
933
Green Plains
GPRE
$635M
| $72.5K | 0.01% |
12,023
-8,553
| -42% | -$51.6K |
|
934
Xeris Biopharma Holdings
XERS
$1.26B
| $72.4K | 0.01% |
+15,500
| New | +$72.4K |
|
|
NEWP
935
New Pacific Metals
NEWP
$363M
| $72.3K | 0.01% |
53,948
-85,952
| -61% | -$115K |
|
|
CMRC
936
Commerce.com, Inc. Series 1 Common Stock
CMRC
$365M
| $71.5K | 0.01% |
+14,300
| New | +$71.5K |
|
937
Granite Ridge Resources
GRNT
$707M
| $70.1K | 0.01% |
+11,000
| New | +$70.1K |
|
938
Protara Therapeutics
TARA
$120M
| $69.1K | 0.01% |
+22,816
| New | +$69.1K |
|
939
ON24
ONTF
$230M
| $69K | 0.01% |
+12,700
| New | +$69K |
|
940
Stereotaxis
STXS
$256M
| $67.7K | 0.01% |
31,943
-10,016
| -24% | -$21.2K |
|
941
Resources Connection
RGP
$167M
| $67K | 0.01% |
12,475
+1,375
| +12% | +$7.38K |
|
942
The RealReal
REAL
$1.02B
| $64.9K | 0.01% |
+13,552
| New | +$64.9K |
|
943
Gain Therapeutics
GANX
$62.2M
| $64.5K | 0.01% |
35,820
| – | – |
|
944
The Honest Company
HNST
$422M
| $62.5K | 0.01% |
+12,281
| New | +$62.5K |
|
945
Cineverse
CNVS
$66M
| $62.1K | 0.01% |
13,000
| – | – |
|
|
INV
946
Innventure, Inc. Common Stock
INV
$314M
| $61.2K | 0.01% |
+12,744
| New | +$61.2K |
|
947
TELUS International
TIXT
$1.25B
| $58K | 0.01% |
+15,982
| New | +$58K |
|
948
Newell Brands
NWL
$2.54B
| $57.8K | 0.01% |
+10,711
| New | +$57.8K |
|
949
Relay Therapeutics
RLAY
$700M
| $57.4K | 0.01% |
16,600
-4,600
| -22% | -$15.9K |
|
950
Abacus Life
ABL
$605M
| $56.8K | 0.01% |
+11,054
| New | +$56.8K |
|